|
Saturday, July 1113
|
Sunday, July 12
|
Monday, July 13
|
Tuesday, July 14
|
|
Plenary Sessions
Educational Sessions
Networking Events
Satellite Symposia
Breaks
|
Networking Lounge
9:00-9:45 am
Molecular Hub – Council & Center Leadership
|
Auditorium
8:45-9:45 am
Special Session – Nuclear Medicine in the Time of COVID-19
|
Networking Lounge
9:00-9:45 am
Molecular Hub – Early Career Professionals
|
|
Auditorium
10:00-11:00 am
SNMMI President’s Address/Wagner Lecture
|
Auditorium
10:00-11:00 am
SNMMI Business Meeting/Cassen Lecture
|
Auditorium
10:00-11:00 am
SNMMI-TS Award Recognition and Plenary
|
|
11:00-11:15 am Break – Visit the Exhibit Hall & the Science Pavilion
|
|
Auditorium
11:15 am-12:15 pm
Complementary Roles of Nuclear Medicine and Radiologic Imaging in the Evaluation of Musculoskeletal Diseases
|
Auditorium
11:15 am-12:15 pm
Theranostics- How to Do Radiation Safety Right?
|
Auditorium
11:15 am-12:15 pm
Practical Aspects and Concerns Associated with USP 825 Implementation
|
|
12:15-12:30 pm Break – Visit the Exhibit Hall & the Science Pavilion
|
|
Auditorium
12:30-1:30 pm
Lymphoscintigraphy: Review of Basics, Use with SPECT/CT, and Viewpoint of a Surgeon
|
Auditorium
12:30-1:30 pm
Best Practices to Support the Quality Control of PET Drugs
|
Auditorium
12:30-1:30 pm
New Imaging Boot Camp: FES, 18F-DOPA, New Net Imaging Agents, FAPI
|
|
1:30-2:30 pm Lunch Break – Visit the Exhibit Hall –
Attend Industry Satellite Symposia (See Titles Below in Grey/Non-CE)
|
|
Networking Lounge
1:30-2:30 pm
Molecular Hub – First Time Attendees
|
Auditorium
The Role of LUTATHERA® (lutetium Lu 177 dotatate) in Patients With Progressive GEP-NETs
Sponsored by Advanced Accelerator Applications
|
Auditorium
Estrogen Receptor PET/CT Imaging
Sponsored by Siemens
|
Auditorium
Clinical Innovations: Artificial Intelligence in PET and SPECT1
Sponsored by Siemens
|
Auditorium
PSMA Imaging: Current Status and Prospects
Sponsored by Telix Pharmaceuticals
|
Auditorium
Critical Considerations in Managing Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
Sponsored by Advanced Accelerator Applications
|
Auditorium
Development and Application of Novel PET Tracer for AMPA Receptors
Sponsored by Eisai
|
|
Auditorium
2:30-3:15 pm
Opening/Welcome
|
Auditorium
2:30-3:30 pm
SPECT/CT Applications in Pediatrics
|
Auditorium
2:30-3:45 pm
Current Perspective on Total Body PET and Applications
|
Auditorium
2:30-3:35 pm
On the Horizon: Developing Techniques, New Isotopes and Production Chemistry
|
|
Auditorium
3:15-4:30 pm
Non-Invasive Evaluation of CAD in 2020
|
Auditorium
3:30-4:30 pm
Fundamentals of Brain SPECT/PET Scan Interpretation in Dementia
|
Auditorium
3:45-4:40 pm
Young Investigator Awards #5 - RPSC
|
Auditorium
3:35-4:30 pm
Young Investigator Awards #6 - Oncology
|
|
4:30-5:00 pm | Visit the Exhibit Hall
|
|
Auditorium
5:00-6:00 pm
Young Investigator Awards #1 - Cardiovascular
|
Auditorium
5:00-6:00 pm
Young Investigator Awards #3 – PIDS
|
Auditorium
5:00-6:00 pm
Pearls and Pitfalls in PET: DOTATATE, Amyloid, Fluciclovine, PSMA
|
Auditorium
5:00-6:30 pm
Prostate Cancer Theranostics- Applications of Molecular Targeted Radiotherapy
|
|
6:00-6:15 pm Break – Visit the Exhibit Hall & the Science Pavilion
|
|
Auditorium
6:15-7:15 pm
Young Investigator Awards #2 – CMIIT
|
Auditorium
6:15-7:15 pm
Young Investigator Awards #4 – Brain Imaging
|
Auditorium
6:15-7:15 pm
Basic Science Summary Session #2- RPSC
|
Auditorium
6:30-8:30 pm
Henry N. Wagner, Jr. MD Highlights Symposium
|
|
Networking Lounge
7:15-8:15 pm
SNMMI-TS President’s Town Hall/Reception
|
Auditorium
7:15-8:30 pm
Basic Science Summary Session #1 - PIDS
|
Networking Lounge
7:15-8:15 pm
SNMMI President’s Town Hall/Reception
|
|
Networking Lounge
8:15-10:15 pm
Movie Night
Amazon Special Screening of "Radioactive"
Second screening of the movie is available for attendees on
Sunday, July 12 at 3:00 am (ET).
|
Networking Lounge
8:30-9:30 pm
Drink & Think
↓
|
Networking Lounge
8:15-9:15 pm
Drink & Think
↓
|
Networking Lounge
8:30-9:30 pm
SNMMI/NMRO Knowledge Bowl
|
|
|
Phased Re-opening Plans for Pediatric Nuclear Radiology Departments
|
Total Body PET
|
|
|
New PET Radiopharmaceuticals: Practical Tips?
|
Targeted Radionuclide Therapy for Non-thyroid Pediatric Malignancies - What’s Here and What’s on the Horizon?
|
|
|
Artificial Intelligence in Nuclear Medicine
|
Nuclear Medicine and COVID-19
|
|
|
Prostate Imaging with PSMA PET and How it Plays Into Other Imaging Modalities
|
21CFR2Beers... Regulatory Considerations for the Radiopharmaceutical Sciences in 2020
|
|
|
Expert Eyes On Details- Deep Cerebellar Nuclei in Neurodegenerative Imaging - Kuhl-Lassen Award
|
Nuclear Medicine Practice Optimization – Opportunity for Physician Extenders
|
|
|
How Toxic Environments Affect Productivity
|
Resident Training and Recruitment in the Time of COVID
|
|
|
|
What Are You Most Excited About With the Future of Nuclear Medicine Therapies?
|
|